For the quarter ending 2026-03-31, DRMAW has $7,465,652 in assets. $1,052,649 in debts. $6,945,282 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,945,282 | 7,521,978 | 4,664,127 | 6,480,930 |
| Prepaid expenses and other current assets | 427,279 | 341,848 | 407,283 | 159,586 |
| Inventory | 93,091 | - | - | - |
| Total assets | 7,465,652 | 7,863,826 | 5,071,410 | 6,640,516 |
| Accounts payable (including related party amounts of 0 and 86,250, respectively) | 318,331 | 460,811 | 453,427 | 413,687 |
| Accrued and other current liabilities (including related party amounts of 129,333 and 25,000, respectively) | 734,318 | 1,179,635 | 657,881 | 612,578 |
| Total liabilities | 1,052,649 | 1,640,446 | 1,111,308 | 1,026,265 |
| Common stock, par value 0.0001, 250,000,000 shares authorized 4,022,143 shares issued and outstanding as of march 31, 2026 2,660,110 shares issued and outstanding as of december 31, 2025 | 402 | 266 | 84 | 64 |
| Additional paid-in capital | 81,494,203 | 79,457,010 | 75,332,026 | 75,294,206 |
| Accumulated deficit | -75,081,602 | -73,233,896 | -71,372,008 | -69,680,019 |
| Total stockholders equity | 6,413,003 | 6,223,380 | 3,960,102 | 5,614,251 |
| Total liabilities and stockholders equity | 7,465,652 | 7,863,826 | 5,071,410 | 6,640,516 |
Dermata Therapeutics, Inc. (DRMAW)
Dermata Therapeutics, Inc. (DRMAW)